本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

20.30
+0.86004.42%
成交量:50.58万
成交额:1,013.69万
市值:25.51亿
市盈率:-11.30
高:20.33
开:19.58
低:19.25
收:19.44
数据加载中...
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/14

重要事件披露

Form 8-K - Current report
2023/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/01

重要事件披露

Form 8-K - Current report
2023/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/21

SEC问询函

Form CORRESP - Correspondence
2023/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities